Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Summer Drummond"'
Autor:
Nathan Bahary, James Ohr, James J. Lee, Daniel P. Normolle, Edward Chu, Summer Drummond, Weijing Sun, Krishna Patel, Natalie Streeter, Anuj K. Patel
Publikováno v:
Cancer. 125:902-909
Biliary tract cancers are rare, aggressive neoplasms. Most patients present with advanced/unresectable or metastatic disease at diagnosis, and no second-line regimen has demonstrated clinical benefit. This was a phase 2 study evaluating the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4341532d76bcfde63b151df51f146a62
https://doi.org/10.1002/cncr.31872
https://doi.org/10.1002/cncr.31872
Autor:
Mary Reslink, Christine Chubeck, Gloria Gotskie, Janet Lindberg, Rebecca Snyder Brown, Darlene Landi, Kate Ross, Summer Drummond, Susan Siak, Leah Agostino
Publikováno v:
Clinical Journal of Oncology Nursing. 23:431-433
At the University of Pittsburgh Medical Center's Hillman Cancer Center, multiple occurrences of critically elevated partial thromboplastin time (PTT) levels drawn by central venous access devices (implantable ports) were determined to be inaccurate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4aeedeea158f272e9f0c8e751628ce
https://doi.org/10.1188/19.cjon.431-433
https://doi.org/10.1188/19.cjon.431-433
Autor:
Allan Tsung, James J. Lee, J. Wallis Marsh, Herbert J. Zeh, Edward Chu, Summer Drummond, Krishna Patel, Weijing Sun, John P. Morcos, Nathan Bahary, M. Sulecki, James Ohr, Barry C. Lembersky, Daniel P. Normolle, Natalie Streeter, David A. Geller, Anuj K. Patel
Publikováno v:
Journal of Clinical Oncology. 35:4081-4081
4081 Background: Biliary adenocarcinoma/cholangiocarcinoma is a rare but aggressive neoplasm. Most patients present with unresectable or metastatic disease with 5-year survival rate ~5%. No second-line regimen has demonstrated clinical benefit in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93e42c3fae3f72075e6dcf28fa1634f3
https://doi.org/10.1200/jco.2017.35.15_suppl.4081
https://doi.org/10.1200/jco.2017.35.15_suppl.4081
Autor:
Nathan Bahary, Natalie Streeter, Ronald G. Stoller, Edward Chu, James P. Herman, Yongli Shuai, Stanley M. Marks, Weijing Sun, James Ohr, Barry C. Lembersky, Yan Lin, James J. Lee, H. Scott Beasley, Hassane M. Zarour, Summer Drummond, John C. Rhee
Publikováno v:
Journal of Clinical Oncology. 35:3054-3054
3054 Background: Microsatellite stable (MSS) metastatic colorectal cancer (mCRC) has relatively poor tumoral infiltration of CD8+ T cells and is resistant to pembrolizumab (Pembro) when compared to MSI-H mCRC. DNA hypomethylating agent induces epigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7b6b0d617a246c2fd77cda2bed09a74
https://doi.org/10.1200/jco.2017.35.15_suppl.3054
https://doi.org/10.1200/jco.2017.35.15_suppl.3054